The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is There Any Advantage in Chronomodulating 5FU Combined with Taxol in Second or Third-Line Treatment of Metastatic Breast Cancer (MBC)? Results of Two French Multicenter Studies.
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Pfizer; Research to Practice; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Merck; Polaris
 
Fang-Shu Ou
No Relationships to Disclose
 
Daniel M. Anderson
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I); Merrimack
 
Patrick McKay Boland
Consulting or Advisory Role - Sirtex Medical
Research Funding - Boehringer Ingelheim (Inst); Merck (Inst); Theradiag (Inst)
 
Kristen Keon Ciombor
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Incyte; MedImmune; Merck; Novartis; Onyx; Pfizer; Sanofi
 
Nisha Lassi Jacobs
No Relationships to Disclose
 
Rodwige J. Desnoyers
No Relationships to Disclose
 
James M. Cleary
Honoraria - Agios
Research Funding - Merck
Travel, Accommodations, Expenses - Agios; Roche
 
Jeffrey P. Meyers
No Relationships to Disclose
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene; Genentech/Roche; Novocure; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ignyta (Inst); Incyte (Inst); Newlink Genetics (Inst); PRISM Pharma (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche
 
Katrina Pedersen
Speakers' Bureau - Clinical Care Options
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion
 
Jeffrey Sloan
No Relationships to Disclose
 
Jeannine S. McCune
No Relationships to Disclose
 
Mario E. Lacouture
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Boehringer Ingelheim; Foamix; Janssen Research & Development; Legacy Healthcare Services; Novartis; Novocure; Quintiles
Research Funding - Berg Pharma (Inst); Bristol-Myers Squibb
 
Heinz Josef Lenz
Honoraria - Bristol-Myers Squibb; Merck KGaA; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Roche; Roche
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); Roche (Inst); Taiho Pharmaceutical (Inst)
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme